Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Elephantiasis (Lymphatic Filariasis) - Overview
Elephantiasis (Lymphatic Filariasis) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Elephantiasis (Lymphatic Filariasis) - Therapeutics Assessment
Assessment by Route of Administration
Assessment by Molecule Type
Elephantiasis (Lymphatic Filariasis) - Companies Involved in Therapeutics Development
AbbVie Inc
Eisai Co Ltd
Medicines Development for Global Health Ltd
Pai Life Sciences Inc
Elephantiasis (Lymphatic Filariasis) - Drug Profiles
ABBV-4083 - Drug Profile
Product Description
Mechanism Of Action
History of Events
AWZ-1066S - Drug Profile
Product Description
Mechanism Of Action
History of Events
filariasis vaccine - Drug Profile
Product Description
Mechanism Of Action
lymphatic filariasis (multivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
lymphatic filariasis (multivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
moxidectin - Drug Profile
Product Description
Mechanism Of Action
History of Events
Elephantiasis (Lymphatic Filariasis) - Dormant Projects
Elephantiasis (Lymphatic Filariasis) - Product Development Milestones
Featured News & Press Releases
Jan 08, 2019: New anti-Wolbachia drug with potential to treat onchocerciasis and lymphatic filariasis
Sep 14, 2018: ?1.5M to develop candidate drug to treat onchocerciasis and lymphatic filariasis
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Elephantiasis (Lymphatic Filariasis), 2022
Number of Products under Development by Companies, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Elephantiasis (Lymphatic Filariasis), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Elephantiasis (Lymphatic Filariasis) - Pipeline by AbbVie Inc, 2022
Elephantiasis (Lymphatic Filariasis) - Pipeline by Eisai Co Ltd, 2022
Elephantiasis (Lymphatic Filariasis) - Pipeline by Medicines Development for Global Health Ltd, 2022
Elephantiasis (Lymphatic Filariasis) - Pipeline by Pai Life Sciences Inc, 2022
Elephantiasis (Lymphatic Filariasis) - Dormant Projects, 2022